Methods and compositions particularly for treatment of attention deficit disorder Grant US-11896722-B2 United States of America 13 Feb 2024
Controlled release pharmaceutical compositions comprising a fumaric acid ester Grant US-11229619-B2 United States of America 25 Jan 2022
Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix Grant US-11173123-B2 United States of America 16 Nov 2021
A CONTROLLED RELEASE IODINE STRUCTURE FOR USE WITH WOUND CARE Grant EP-3291849-B1 European Patent Office 08 Sep 2021
Controlled release pharmaceutical compositions comprising a fumaric acid ester Grant US-11052062-B2 United States of America 06 Jul 2021
Methods and compositions particularly for treatment of attention deficit disorder Grant US-10722473-B2 United States of America 28 Jul 2020
Methods and compositions particularly for treatment of attention deficit disorder Grant US-10688060-B2 United States of America 23 Jun 2020
Methods and compositions particularly for treatment of attention deficit disorder Grant US-10568841-B2 United States of America 25 Feb 2020
Methods and compositions particularly for treatment of attention deficit disorder Grant US-10512613-B2 United States of America 24 Dec 2019
Methods and compositions particularly for treatment of attention deficit disorder Grant US-10512612-B2 United States of America 24 Dec 2019
Methods and compositions particularly for treatment of attention deficit disorder Grant US-10507186-B2 United States of America 17 Dec 2019
Methods and compositions particularly for treatment of attention deficit disorder Grant US-10500162-B2 United States of America 10 Dec 2019
Methods and compositions particularly for treatment of attention deficit disorder Grant US-10449159-B2 United States of America 22 Oct 2019
Methods and compositions particularly for treatment of attention deficit disorder Grant US-10292939-B2 United States of America 21 May 2019
Methods and compositions particularly for treatment of attention deficit disorder Grant US-10292938-B2 United States of America 21 May 2019
Methods and compositions particularly for treatment of attention deficit disorder Grant US-10111839-B2 United States of America 30 Oct 2018
Methods of treating attention deficit hyperactivity disorder Grant US-10039719-B2 United States of America 07 Aug 2018
Methods of preparing oral controlled release formulations Grant US-10022330-B2 United States of America 17 Jul 2018
Methods and compositions particularly for treatment of attention deficit disorder Grant US-9974752-B2 United States of America 22 May 2018
Methods of treating attention deficit hyperactivity disorder Grant US-9949931-B2 United States of America 24 Apr 2018
Controlled release formulations having rapid onset and rapid decline of effective plasma… Grant US-9801823-B2 United States of America 31 Oct 2017
Use of fumaric acid derivatives for treating cardiac insufficiency, and asthma Grant US-8980832-B2 United States of America 17 Mar 2015
Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix Grant US-8906420-B2 United States of America 09 Dec 2014
PHARMACEUTICAL COMPOSITION WITH CONTROLLED RELEASE OF METABOLICALLY ACTIVE SUGAR Application WO-2014180453-A1 World Intellectual Property Organisation (WIPO) 13 Nov 2014
TECHNOLOGY FOR PREVENTING ABUSE OF SOLID DOSAGE FORMS Application US-20120321716-A1 United States of America 20 Dec 2012